Loading clinical trials...

Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT05459571

Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma

The goal of this clinical study is to learn more about the study drug, axicabtagene ciloleucel, in participants with relapsed or refractory large B-cell lymphoma (LBCL) in the outpatient setting.

Lead sponsor: Kite, A Gilead Company•16 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

Not Yet RecruitingPhase 3

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

NCT07479797 · Relapsed or Refractory Large B-cell Lymphoma

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 2, 2026Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment35

Start dateAug 2022

Last updatedFeb 2, 2026

Condition

Relapsed or Refractory Large B-cell Lymphoma

Locations shown

City of Hope (City of Hope National Medical Center, City of Hope Medical Center)

Duarte, California

UCLA

Los Angeles, California

Colorado Blood Cancer Institute

Denver, Colorado

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions